Colgate-Palmoliv

INR
1,849.35
-46.8 (-2.47%)
BSENSE

Mar 23

BSE+NSE Vol: 3.67 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.67 lacs (16.44%) Volume

Shareholding (Dec 2025)

FII

15.18%

Held by 671 FIIs

DII

0.71%

Held by 32 DIIs

Promoter

51.00%

how big is Colgate-Palmoliv?

06-Jun-2025

As of Jun 06, Colgate-Palmolive (India) Ltd has a market capitalization of 66,262.50 Cr and reported Net Sales of 5999.20 Cr and a Net Profit of 1436.81 Cr for the latest four quarters.

Market Cap: <BR>As of Jun 06, Colgate-Palmolive (India) Ltd has a market capitalization of 66,262.50 Cr, categorizing it as a Large Cap company.<BR><BR>Recent Quarterly Performance: <BR>For the latest 4 quarters, the company reported Net Sales of 5999.20 Cr and a Net Profit of 1436.81 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: <BR>The Balance Sheet data is Consolidated and pertains to the latest annual period of Mar'10. Shareholder's Funds are reported at 330.22 Cr, while Total Assets amount to 867.10 Cr.

View full answer

Who are in the management team of Colgate-Palmoliv?

06-Jun-2025

As of March 2022, Colgate-Palmolive's management team includes V S Mehta, Indu Shahani, Shyamala Gopinath, M S Jacob, Mukul Deoras, Sukanya Kripalu, Sekhar Natarajan, GOPIKA PANT, Surender Sharma, PRABHA NARASIMHAN, and Indu Bhushan, featuring a mix of independent and executive directors.

As of March 2022, the management team of Colgate-Palmolive includes the following individuals:<BR><BR>1. V S Mehta - Independent Director<BR>2. Indu Shahani - Independent Director<BR>3. Shyamala Gopinath - Independent Director<BR>4. M S Jacob - Whole Time Director & CFO<BR>5. Mukul Deoras - Chairman (Non-Executive)<BR>6. Sukanya Kripalu - Independent Director<BR>7. Sekhar Natarajan - Independent Director<BR>8. GOPIKA PANT - Independent Director<BR>9. Surender Sharma - Whole-time Director & CS<BR>10. PRABHA NARASIMHAN - Managing Director & CEO<BR>11. Indu Bhushan - Additional Director<BR><BR>This team comprises a mix of independent directors, executive directors, and non-executive leadership, reflecting a diverse governance structure.

View full answer

What does Colgate-Palmoliv do?

06-Jun-2025

Colgate-Palmolive (India) Limited is a leading FMCG company specializing in oral care products, with a recent net sales of ₹1,452 Cr and a net profit of ₹355 Cr as of March 2025. It operates as a subsidiary of Colgate-Palmolive, USA, and has a market capitalization of ₹66,265 Cr.

Overview: <BR>Colgate-Palmolive (India) Limited is a leading provider of scientifically proven oral care products in the FMCG sector, classified as a large-cap company.<BR><BR>History: <BR>Colgate-Palmolive (India) Ltd is a subsidiary of Colgate-Palmolive, USA. The company has been operational for several years, with the latest quarterly results reported for March 2025, showcasing its ongoing presence in the market.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1,452 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 355 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 66,265 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 46.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.98% <BR>Debt-Equity: -0.62 <BR>Return on Equity: 86.32% <BR>Price to Book: 40.07<BR><BR>Contact Details: <BR>Address: Colgate Research Ctr Main St, Hiranandani Gardens Powai Mumbai Maharashtra : 400076 <BR>Tel: 91-022-67095050 <BR>Email: investor_grievance@colpal.com <BR>Website: http://www.colgatepalmolive.co.in

View full answer

What is the bonus history of the Colgate-Palmoliv?

06-Jun-2025

Colgate-Palmolive (India) Ltd's most recent bonus issue was a 1:1 bonus announced on September 23, 2015, with a record date of September 24, 2015, allowing shareholders to receive an additional share for each share owned.

Colgate-Palmolive (India) Ltd has a notable bonus history, with its latest bonus issue being a 1:1 bonus announced on September 23, 2015. The record date for this bonus was September 24, 2015. This means that shareholders received an additional share for every share they owned at that time. If you have any more questions about the company or its financials, feel free to ask!

View full answer

Who are the peers of the Colgate-Palmoliv?

03-Jun-2025

Colgate-Palmoliv's peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, P&G Hygiene, Godfrey Phillips, Gillette India, and Emami. Most peers exhibit excellent management risk and capital structure, with varying growth rates and returns, where Godfrey Phillips leads in 1-year return at 123.46% and Colgate-Palmoliv shows a -7.80% return.

Peers: The peers of Colgate-Palmoliv are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, P&G Hygiene, Godfrey Phillips, Gillette India, and Emami.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, Britannia Inds., P&G Hygiene, Gillette India, and Emami, while Good management risk is found at Hind. Unilever and Godrej Consumer, and the rest. Below Average growth is noted for Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Colgate-Palmoliv, P&G Hygiene, and Emami, while Average growth is found at Nestle India, and the rest. All peers have Excellent capital structure except Hatsun Agro, which has Average capital structure.<BR><BR>Return Snapshot: Godfrey Phillips has the highest 1-year return at 123.46%, while P&G Hygiene has the lowest at -16.16%. Colgate-Palmoliv’s 1-year return is -7.80%, which is higher than P&G Hygiene's but lower than Godfrey Phillips'. Additionally, the six-month return is negative for Colgate-Palmoliv, P&G Hygiene, and Emami.

View full answer

Is Colgate-Palmoliv overvalued or undervalued?

09-Jun-2025

As of April 12, 2023, Colgate-Palmolive is considered very expensive with a PE ratio of 46.11 and has underperformed the Sensex with a year-to-date return of -9.04%, indicating it may be overvalued at its current price of 2439.40.

As of 12 April 2023, the valuation grade for Colgate-Palmolive has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued, with a PE ratio of 46.11, a price to book value of 39.80, and an EV to EBITDA ratio of 33.30. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Colgate-Palmolive's valuation metrics are notably high, with Hindustan Unilever at a PE of 53.88 and Nestle India at a staggering PE of 75.2, both classified as very expensive. Despite being in a competitive landscape, Colgate-Palmolive's ratios indicate it is priced higher than many of its industry counterparts. The company's stock has underperformed relative to the Sensex, with a year-to-date return of -9.04% compared to the Sensex's 5.59%, reinforcing the notion that it may be overvalued at its current price of 2439.40.

View full answer

Who are the top shareholders of the Colgate-Palmoliv?

17-Jul-2025

The top shareholders of Colgate-Palmolive include the company itself with 40.06%, foreign institutional investors at 22.22%, mutual funds with 4.69%, individual investors holding 16.56%, and the Life Insurance Corporation of India as the largest public shareholder at 1.68%. There are no pledged promoter holdings.

The top shareholders of Colgate-Palmolive include the Colgate-Palmolive Company, which holds the largest stake at 40.06%. Other significant shareholders are foreign institutional investors (FIIs), who collectively own 22.22%, and mutual funds, which are held by 34 schemes representing 4.69%. Additionally, individual investors hold 16.56% of the company, while the highest public shareholder is the Life Insurance Corporation of India, with a stake of 1.68%. There are no pledged promoter holdings, indicating a strong position among the promoters.

View full answer

How has been the historical performance of Colgate-Palmoliv?

24-Oct-2025

Colgate-Palmoliv demonstrated consistent growth from March 2007 to March 2010, with net sales increasing from 1,295.62 Cr to 1,962.46 Cr and profit after tax rising from 148.39 Cr to 434.10 Cr, reflecting improved operational efficiency and profitability. Key metrics such as EPS and cash flow also showed significant gains during this period.

Answer:<BR>The historical performance of Colgate-Palmoliv shows a consistent growth trend across various financial metrics from March 2007 to March 2010.<BR><BR>Breakdown:<BR>Colgate-Palmoliv's net sales increased from 1,295.62 Cr in March 2007 to 1,962.46 Cr in March 2010, reflecting a strong upward trajectory. Other operating income also rose, contributing to a total operating income that grew from 1,295.62 Cr in March 2007 to 2,032.90 Cr in March 2010. The total expenditure, excluding depreciation, increased from 1,145.55 Cr to 1,525.28 Cr during the same period, but the operating profit (PBDIT) saw a significant rise from 216.00 Cr to 532.55 Cr, indicating improved operational efficiency. Profit before tax followed a similar trend, climbing from 195.45 Cr to 500.39 Cr, while profit after tax surged from 148.39 Cr to 434.10 Cr. The earnings per share (EPS) also demonstrated substantial growth, increasing from 5.46 in March 2007 to 15.96 in March 2010. Operating profit margins improved from 11.58% to 24.97%, and the profit after tax margin increased from 11.45% to 21.43%, showcasing enhanced profitability. Cash flow from operating activities rose from 157.68 Cr to 403.99 Cr, contributing to a closing cash and cash equivalent balance that grew from 114.86 Cr to 347.67 Cr, indicating a solid liquidity position. Overall, Colgate-Palmoliv exhibited robust financial performance over the analyzed period.

View full answer

Has Colgate-Palmoliv declared dividend?

24-Oct-2025

Yes, Colgate-Palmolive (India) Ltd has declared a dividend of 2400% (₹24 per share) with an ex-date of November 3, 2025. Despite recent price volatility, total returns over the 2 to 5-year periods have shown positive trends.

Colgate-Palmolive (India) Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 2400%<BR>- Amount per share: 24<BR>- Ex-date: 03 Nov 25<BR><BR>Dividend Yield: 1.05%.<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -0.97%, the dividend return was 1.09%, resulting in a total return of 0.12%.<BR><BR>In the 6-month period, the price return was -18.0%, the dividend return was 0.89%, leading to a total return of -17.11%.<BR><BR>In the 1-year period, the price return was -30.77%, the dividend return was 1.55%, which resulted in a total return of -29.22%.<BR><BR>In the 2-year period, the price return was 7.81%, the dividend return was 4.54%, culminating in a total return of 12.35%.<BR><BR>In the 3-year period, the price return was 40.2%, the dividend return was 7.38%, resulting in a total return of 47.58%.<BR><BR>In the 4-year period, the price return was 43.03%, the dividend return was 10.23%, leading to a total return of 53.26%.<BR><BR>In the 5-year period, the price return was 52.64%, the dividend return was 12.86%, culminating in a total return of 65.5%.<BR><BR>Overall, Colgate-Palmolive (India) Ltd has declared a significant dividend, and while recent price returns have shown volatility, the total returns over longer periods indicate a positive trend, particularly in the 2 to 5-year ranges.

View full answer

Is Colgate-Palmoliv technically bullish or bearish?

19-Nov-2025

As of November 18, 2025, the market trend has shifted to bearish with moderate strength, driven by daily moving averages and monthly indicators, despite some mildly bullish signals on the weekly timeframe.

As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating a bearish trend, the monthly MACD and Bollinger Bands both showing bearish signals, and the Dow Theory reflecting a mildly bearish outlook on both weekly and monthly time frames. Although the weekly MACD and KST are mildly bullish, they are overshadowed by the overall bearish sentiment in the longer-term indicators.

View full answer

When is the next results date for Colgate-Palmolive (India) Ltd?

21-Jan-2026

The next results date for Colgate-Palmolive (India) Ltd is January 29, 2026.

The next results date for Colgate-Palmolive (India) Ltd is scheduled for January 29, 2026.

View full answer

Are Colgate-Palmolive (India) Ltd latest results good or bad?

30-Jan-2026

Colgate-Palmolive (India) Ltd's latest results show a significant decline in net profit by 17.09% and net sales by 6.34% year-on-year, indicating ongoing challenges in the FMCG sector. Analysts have rated the stock as a "Strong Sell" due to concerns over the company's near-term recovery prospects.

Colgate-Palmolive (India) Ltd's latest results indicate a challenging period for the company. In Q3 FY26, the net profit was ₹327.51 crore, which represents a significant decline of 17.09% year-on-year. Similarly, net sales fell to ₹1,507.24 crore, down 6.34% from the previous year. Although there was a slight sequential improvement in sales compared to the previous quarter, the year-on-year contraction highlights ongoing structural issues.<BR><BR>The operating margin remained relatively stable at 30.88%, but this is a slight decrease from the previous year. The profit after tax margin also saw a notable decline, dropping to 21.73% from 24.55% a year earlier, reflecting operational pressures and a decrease in other income.<BR><BR>Overall, the results suggest that Colgate-Palmolive is facing significant challenges, particularly with volume growth and competitive pressures in the FMCG sector. The stock has also underperformed compared to the broader market, leading to a "Strong Sell" rating from analysts due to concerns about the company's near-term recovery prospects. Investors should be cautious, as the current financial trends indicate a negative outlook for the company.

View full answer

Should I buy, sell or hold Colgate-Palmolive (India) Ltd?

12-Mar-2026

Why is Colgate-Palmolive (India) Ltd falling/rising?

17-Mar-2026

As of 17-Mar, Colgate-Palmolive (India) Ltd's stock price is declining at 1,932.00, down -0.41%, with a significant drop of -12.29% over the past week and -10.18% over the past month. This decline is driven by poor growth indicators, underperformance compared to the market, and decreased investor interest.

As of 17-Mar, Colgate-Palmolive (India) Ltd is experiencing a decline in its stock price, currently at 1,932.00, which reflects a change of -7.95 (-0.41%). The stock has been on a downward trend, losing -12.29% over the past week and -10.18% over the past month. This consistent decline is attributed to several factors, including poor long-term growth indicators, as evidenced by a net sales growth rate of only 4.98% and an operating profit growth rate of 7.91% over the last five years.<BR><BR>Additionally, the stock has underperformed significantly compared to the market, generating a return of -18.96% over the past year, while the broader market (BSE500) has returned 6.18%. The company's financial metrics also reveal concerning trends, such as the lowest Debtors Turnover Ratio at 26.36 times and a low Operating Profit to Net Sales ratio of 29.74%, indicating operational inefficiencies.<BR><BR>Investor participation has also decreased, with delivery volume falling by -51.86% against the five-day average, suggesting waning interest among investors. Furthermore, the stock is trading below its moving averages across various time frames, indicating a bearish trend. Despite high management efficiency and low debt levels, these negative performance indicators and market underperformance contribute to the stock's current decline.

View full answer

Why is Colgate-Palmolive (India) Ltd falling/rising?

18-Mar-2026

As of 18-Mar, Colgate-Palmolive (India) Ltd's stock price is 1,942.00, having risen slightly after a decline, but it remains in a bearish trend with poor long-term growth and reduced investor participation. Despite high management efficiency, the stock's overall performance and outlook suggest potential further declines.

As of 18-Mar, Colgate-Palmolive (India) Ltd's stock price is currently at 1,942.00, reflecting a change of 9.15 (0.47%) upward. This rise comes after a trend reversal, as the stock has gained after five consecutive days of decline. Despite this recent uptick, the stock has shown poor performance over various periods, including a 1-week decline of 5.47% and a 1-month decline of 11.86%. <BR><BR>The stock is also trading lower than its moving averages across multiple time frames, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 51.16% compared to the 5-day average. This suggests a lack of confidence among investors, contributing to the stock's overall downward trajectory in the longer term.<BR><BR>While the company boasts high management efficiency with a return on equity (ROE) of 73.11% and a low debt-to-equity ratio, these positives are overshadowed by poor long-term growth metrics. The net sales growth has been only 4.98% annually over the last five years, and the stock has generated a return of -20.51% over the past year, with profits declining by 8.8%. <BR><BR>Overall, despite the slight rise in price today, the broader context of declining performance, reduced investor participation, and poor long-term growth prospects indicates that Colgate-Palmolive (India) Ltd is facing significant challenges that could lead to further declines in its stock price.

View full answer

Why is Colgate-Palmolive (India) Ltd falling/rising?

19-Mar-2026

As of 19-Mar, Colgate-Palmolive (India) Ltd is facing a stock price decline to 1,889.55, down -2.7%, attributed to hitting a new 52-week low, underperforming the Sensex, and declining investor interest. The stock's bearish trend is further indicated by trading below all moving averages and poor long-term growth metrics.

As of 19-Mar, Colgate-Palmolive (India) Ltd is experiencing a decline in its stock price, currently at 1,889.55, which reflects a change of -52.45 (-2.7%). This drop can be attributed to several factors highlighted in the source data. <BR><BR>Firstly, the stock has hit a new 52-week low of Rs.1885.6 today, indicating significant downward pressure. The stock's performance over the past week shows a decline of -4.38%, which is worse than the benchmark Sensex's drop of -2.40%. Over the past month, the stock has decreased by -12.81%, again underperforming the Sensex, which fell by -10.05%. Year-to-date, the stock is down -8.97%, while the Sensex has decreased by -12.92%. <BR><BR>Additionally, the stock is trading below all its moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), which suggests a bearish trend. The falling investor participation is also concerning, with delivery volume dropping by -62.18% compared to the 5-day average, indicating reduced interest from investors.<BR><BR>Despite some positive factors such as high management efficiency and low debt levels, the company has shown poor long-term growth, with net sales growing at an annual rate of only 4.98% and operating profit at 7.91% over the last five years. Furthermore, recent negative results, including a low debtors turnover ratio and a significant decline in operating profit to net sales, have contributed to the stock's weak performance. <BR><BR>Overall, the combination of hitting a new low, underperformance relative to the market, declining investor interest, and poor growth metrics are key reasons for the falling stock price of Colgate-Palmolive (India) Ltd.

View full answer

Why is Colgate-Palmolive (India) Ltd falling/rising?

20-Mar-2026

As of 20-Mar, Colgate-Palmolive (India) Ltd's stock price is Rs 1,897.00, reflecting a slight increase despite significant challenges, including a 3.06% decline over the past week and an 8.61% drop year-to-date. The stock is trading near its 52-week low and shows bearish trends, indicating ongoing pressure amid poor long-term growth prospects.

As of 20-Mar, Colgate-Palmolive (India) Ltd is experiencing a slight rise in its stock price, currently at Rs 1,897.00, reflecting an increase of 7.45 (0.39%). However, this upward movement occurs against a backdrop of significant challenges for the company. <BR><BR>Over the past week, the stock has declined by 3.06%, and it has seen a more substantial drop of 13.59% over the past month. Year-to-date, the stock is down 8.61%, and it has fallen 21.65% over the last year. This poor performance is compounded by the fact that the stock is trading close to its 52-week low, just 0.6% away from Rs 1,885.6.<BR><BR>The stock's performance is also characterized by lower trading volumes, with a delivery volume that has decreased by 25.46% compared to the 5-day average. Additionally, Colgate-Palmolive is trading below its moving averages across various time frames, indicating a bearish trend.<BR><BR>Despite some positive factors, such as high management efficiency and low debt levels, the company faces significant long-term growth challenges. Its net sales have only grown at an annual rate of 4.98% over the last five years, and its operating profit growth stands at 7.91%. Furthermore, recent financial results have shown negative trends, including the lowest debtor turnover ratio and operating profit to net sales ratio recorded.<BR><BR>Overall, while there is a minor uptick in the stock price on this particular day, the broader context of declining performance metrics, poor long-term growth prospects, and reduced investor participation suggests that the stock remains under pressure.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 4.98% and Operating profit at 7.91% over the last 5 years

 
2

Negative results in Dec 25

3

With ROE of 84.3, it has a Very Expensive valuation with a 32.6 Price to Book Value

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

INR 50,300 Cr (Mid Cap)

stock-summary
P/E

39.00

stock-summary
Industry P/E

45

stock-summary
Dividend Yield

1.27%

stock-summary
Debt Equity

-0.81

stock-summary
Return on Equity

84.26%

stock-summary
Price to Book

32.61

Revenue and Profits:
Net Sales:
1,473 Cr
(Quarterly Results - Dec 2025)
Net Profit:
324 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.27%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.17%
0%
-12.17%
6 Months
-20.45%
1.04%
-19.41%
1 Year
-23.09%
1.00%
-22.09%
2 Years
-31.71%
2.66%
-29.05%
3 Years
21.63%
7.62%
29.25%
4 Years
21.08%
10.19%
31.27%
5 Years
17.79%
11.40%
29.19%

Latest dividend: 24 per share ex-dividend date: Nov-03-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Press Release / Media Release

23-Feb-2026 | Source : BSE

Please find herewith attached press release

Announcement under Regulation 30 (LODR)-Press Release / Media Release

20-Feb-2026 | Source : BSE

Please find herewith attached Press Release

Announcement under Regulation 30 (LODR)-Press Release / Media Release

13-Feb-2026 | Source : BSE

Please find attached herewith Media Release.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Colgate-Palmolive (India) Ltd has declared 2400% dividend, ex-date: 03 Nov 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Colgate-Palmolive (India) Ltd has announced 1:1 bonus issue, ex-date: 23 Sep 15

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
4.98%
EBIT Growth (5y)
7.91%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.81
Sales to Capital Employed (avg)
3.15
Tax Ratio
25.76%
Dividend Payout Ratio
119.18%
Pledged Shares
0
Institutional Holding
28.97%
ROCE (avg)
281.56%
ROE (avg)
73.11%

Valuation key factors

Factor
Value
P/E Ratio
39
Industry P/E
45
Price to Book Value
32.61
EV to EBIT
29.44
EV to EBITDA
27.08
EV to Capital Employed
170.61
EV to Sales
8.52
PEG Ratio
NA
Dividend Yield
1.27%
ROCE (Latest)
582.00%
ROE (Latest)
84.26%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 30 Schemes (6.11%)

FIIs

Held by 671 FIIs (15.18%)

Promoter with highest holding

Colgate-palmolive Company (40.06%)

Highest Public shareholder

Life Insurance Corporation Of India (3.81%)

Individual Investors Holdings

17.51%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -2.28% vs 6.10% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -1.11% vs 2.15% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,472.92",
          "val2": "1,507.24",
          "chgp": "-2.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "442.03",
          "val2": "465.43",
          "chgp": "-5.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.97",
          "val2": "0.99",
          "chgp": "-2.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.39",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "323.86",
          "val2": "327.51",
          "chgp": "-1.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.01%",
          "val2": "30.88%",
          "chgp": "-0.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Colgate-Palmoliv"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Colgate-Palmoliv"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 6.33% vs 8.69% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 8.55% vs 26.41% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,040.17",
          "val2": "5,680.43",
          "chgp": "6.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,991.18",
          "val2": "1,928.93",
          "chgp": "3.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.32",
          "val2": "5.00",
          "chgp": "-13.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-19.50",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,436.81",
          "val2": "1,323.66",
          "chgp": "8.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.27%",
          "val2": "30.94%",
          "chgp": "-0.67%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
1,472.92
1,507.24
-2.28%
Operating Profit (PBDIT) excl Other Income
442.03
465.43
-5.03%
Interest
0.97
0.99
-2.02%
Exceptional Items
-8.39
0.00
Standalone Net Profit
323.86
327.51
-1.11%
Operating Profit Margin (Excl OI)
30.01%
30.88%
-0.87%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -2.28% vs 6.10% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -1.11% vs 2.15% in Sep 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
6,040.17
5,680.43
6.33%
Operating Profit (PBDIT) excl Other Income
1,991.18
1,928.93
3.23%
Interest
4.32
5.00
-13.60%
Exceptional Items
0.00
-19.50
100.00%
Consolidate Net Profit
1,436.81
1,323.66
8.55%
Operating Profit Margin (Excl OI)
30.27%
30.94%
-0.67%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 6.33% vs 8.69% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 8.55% vs 26.41% in Mar 2024

stock-summaryCompany CV
About Colgate-Palmolive (India) Ltd stock-summary
stock-summary
Colgate-Palmolive (India) Ltd
Mid Cap
FMCG
Colgate-Palmolive (India) Limited is a subsidiary of Colgate-Palmolive, USA. The Company is India's leading provider of scientifically proven oral care products. The range includes toothpastes, toothpowder, toothbrushes and mouthwashes under the 'Colgate' brand, as well as a specialized range of dental therapies under the banner of Colgate Oral Pharmaceuticals. The Company is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.
Company Coordinates stock-summary
Company Details
Colgate Research Ctr Main St, Hiranandani Gardens Powai Mumbai Maharashtra : 400076
stock-summary
Tel: 91-022-67095050
stock-summary
investor_grievance@colpal.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai